115 related articles for article (PubMed ID: 3491964)
1. Effect of nicotine and amphetamine on the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice.
Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
Neuropharmacology; 1986 Nov; 25(11):1231-4. PubMed ID: 3491964
[TBL] [Abstract][Full Text] [Related]
2. Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice.
Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
Neuropharmacology; 1986 Aug; 25(8):927-30. PubMed ID: 3490630
[TBL] [Abstract][Full Text] [Related]
3. The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on presynaptic dopamine uptake sites in the mouse striatum.
Donnan GA; Kaczmarczyk SJ; Rowe PJ; Figdor R; Mendelsohn FA
J Neurol Sci; 1986 Jun; 74(1):111-9. PubMed ID: 3487620
[TBL] [Abstract][Full Text] [Related]
4. Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid.
Sershen H; Reith ME; Hashim A; Lajtha A
Neuropharmacology; 1985 Dec; 24(12):1257-9. PubMed ID: 3879338
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse.
Sershen H; Hashim A; Wiener HL; Lajtha A
Neurosci Lett; 1988 Nov; 93(2-3):270-4. PubMed ID: 3266524
[TBL] [Abstract][Full Text] [Related]
6. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.
Ricaurte GA; Langston JW; DeLanney LE; Irwin I; Brooks JD
Neurosci Lett; 1985 Sep; 59(3):259-64. PubMed ID: 3932903
[TBL] [Abstract][Full Text] [Related]
7. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
Ricaurte GA; Langston JW; Delanney LE; Irwin I; Peroutka SJ; Forno LS
Brain Res; 1986 Jun; 376(1):117-24. PubMed ID: 3487376
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD
Eur J Pharmacol; 1995 Apr; 277(2-3):235-41. PubMed ID: 7493614
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D1 receptor and dopamine D2 receptor binding activity changes during chronic administration of nicotine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Wiener HL; Lajtha A; Sershen H
Neuropharmacology; 1989 May; 28(5):535-7. PubMed ID: 2657481
[TBL] [Abstract][Full Text] [Related]
10. Regional and temporal effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine uptake sites in mouse brain.
Donnan GA; Kaczmarczyk SJ; McKenzie JS; Rowe PJ; Kalnins RM; Mendelsohn FA
J Neurol Sci; 1987 Nov; 81(2-3):261-71. PubMed ID: 3501002
[TBL] [Abstract][Full Text] [Related]
11. Alteration of neurotensin receptors in MPTP-treated mice.
Tanji H; Araki T; Fujihara K; Nagasawa H; Itoyama Y
Peptides; 1999; 20(7):803-7. PubMed ID: 10477079
[TBL] [Abstract][Full Text] [Related]
12. Effect of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on age-related changes in dopamine turnover and transporter function in the mouse striatum.
Sershen H; Mason MF; Hashim A; Lajtha A
Eur J Pharmacol; 1985 Jul; 113(1):135-6. PubMed ID: 3876226
[No Abstract] [Full Text] [Related]
13. Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTP.
Melamed E; Rosenthal J; Cohen O; Uzzan A; Globus M
Neuropharmacology; 1985 Sep; 24(9):923-5. PubMed ID: 3877249
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine-induced circling behaviour in MPTP-lesioned mice.
Fung YK; Troxel CE
J Pharm Pharmacol; 1985 Dec; 37(12):922-3. PubMed ID: 2868107
[TBL] [Abstract][Full Text] [Related]
15. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
Mayer RA; Kindt MV; Heikkila RE
J Neurochem; 1986 Oct; 47(4):1073-9. PubMed ID: 3489072
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
17. Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.
Boyce S; Kelly E; Reavill C; Jenner P; Marsden CD
Biochem Pharmacol; 1984 Jun; 33(11):1747-52. PubMed ID: 6610420
[TBL] [Abstract][Full Text] [Related]
18. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
Ofori S; Heikkila RE; Nicklas WJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):258-66. PubMed ID: 2571719
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
Sershen H; Mason MF; Debler EA; Lajtha A
Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
[TBL] [Abstract][Full Text] [Related]
20. Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity in mouse brain by piroheptine and trihexyphenidyl.
Saitoh T
J Neurol Sci; 1988 Feb; 83(2-3):161-6. PubMed ID: 3258627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
